FACTORS THAT INFLUENCE BEMPEDOIC ACID-MEDIATED REDUCTIONS IN HIGH-SENSITIVITY C-REACTIVE PROTEIN: ANALYSIS OF POOLED PATIENT-LEVEL DATA FROM PHASE 3 CLINICAL TRIALS
2020
Reduced high-sensitivity C-reactive protein (hsCRP) levels are associated with lower atherosclerotic cardiovascular disease (ASCVD) risk. Bempedoic acid (BA) is an investigational, ATP-citrate lyase inhibitor in development for treatment of hypercholesterolemia. Prior clinical trial data support BA
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI